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Erratum
J. F. Rosen, M. E. Markowitz, P. E. Bijur, S. T. Jenks, L. Wielopolski, J. A. Kale-Ezra, and D. N. Slatkin.
Sequential Measurements of Bone Lead Content by L X-Ray Fluorescence in CaNa2EDTA-Treated Lead-Toxic
Children. Environmental Health Perspectives, 91: 57-62 (1990).
Figur-e 2 is incomplete in that only part A was printed. Parts B, C, and D were inadvertently omitted. The figure is printed below in its entir ety.
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FIGURE 2. Sequential values for(A) PbB, (B) EP, (C) PbU/EDTA ratios, and (D) net corrected LXRF counts are shown in children at enrollmentand
6 weeks and 6 months after enrollment. Rx = 0 indicates lead-toxic children who did not qualify for CaNa2EDTA treatment; Rx = 1 repr esents
children treated with one in-hospital course ofCaNa2EDTA afterobtaining baseline values atenrollment; and Rx = 2 indicates lead-toxic children
treated in the hospital with CaNa2EDTA after baseline values were obtained at enrollment and again 6 weeks postenrollment.
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